SCHEMBL861495

SCHEMBL861495

COC(=O)c1cc(Br)ccc1Br

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN2 P17706 2/20 0.54
PTPN1 P18031 2/20 0.54
PTPN6 P29350 1/20 0.54
NR4A2 P43354 1/20 0.54
ALDH1A1 P00352 1/20 0.53
GAA P10253 1/20 0.53
MAPT P10636 1/20 0.51
RAB9A P51151 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.50
HSD17B10 Q99714 1/20 0.49
SLC6A3 Q01959 1/20 0.49
POLB P06746 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CHEK1 O14757 1/20 0.44
TSHR P16473 1/20 0.44
HTT P42858 1/20 0.44
CA12 O43570 2/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA7 P43166 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4577829 0.86 NR4A2 (0.56) NR4A2ALDH1A1GAAMAPTL3MBTL1
SCHEMBL29773857 0.86 NR4A2 (0.56) NR4A2ALDH1A1GAAMAPTL3MBTL1
SCHEMBL2482051 0.84 NR4A2 (0.54) NR4A2ALDH1A1GAAMAPTL3MBTL1
SCHEMBL3839211 0.84 NR4A2 (0.54) NR4A2ALDH1A1GAAMAPTL3MBTL1
SCHEMBL30017691 0.82 NR4A2 (0.53) NR4A2ALDH1A1GAAMAPTRAB9A
SCHEMBL205635 0.82 CA12 (0.67) NR4A2ALDH1A1GAAMAPTL3MBTL1
SCHEMBL221754 0.82 CYP46A1 (0.53) NR4A2ALDH1A1GAAMAPTL3MBTL1
SCHEMBL177377 0.82 CA12 (0.67) NR4A2GAASMN1; SMN2TSHRCA12
SCHEMBL30362168 0.82 CA12 (0.67) NR4A2ALDH1A1GAAMAPTL3MBTL1
SCHEMBL155514 0.82 NR4A2 (0.53) NR4A2ALDH1A1GAAMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116947634-A Preparation method of 2, 5-dibromo methyl benzoate 清源创新实验室 2023-10-27 CN claimed
CN-114539537-B Adhesive for electrode material of lithium ion battery and preparation method thereof 中化国际(控股)股份有限公司 2023-06-06 CN claimed
CN-114539537-A Binder for lithium ion battery electrode material and preparation method thereof 中化国际(控股)股份有限公司 2022-05-27 CN claimed
CN-110698377-A Fluorescent small molecular probe based on single benzene ring and synthetic method thereof 西安工程大学 2020-01-17 CN claimed
US-20250163211-A1 MIXED SOLID-STATE IONIC-ELECTRONIC POLYMER CONDUCTORS FOR ELECTROCHEMICAL DEVICES U.S. DEPARTMENT OF ENERGY 2025-05-22 US disclosed
WO-2025010407-A2 NANOSCALE METAL-ORGANIC FRAMEWORKS WITH X-RAY TRIGGERABLE PRODRUGS FOR COMBINATION RADIOTHERAPY, CHEMOTHERAPY, AND IMMUNOTHERAPY THE UNIVERSITY OF CHICAGO (US) 2025-01-09 WO disclosed
WO-2024020244-A2 MIXED SOLID-STATE IONIC-ELECTRONIC POLYMER CONDUCTORS FOR ELECTROCHEMICAL DEVICES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-01-25 WO disclosed
CN-117326927-A Preparation method of 2,5-bis (2, 2-trifluoroethoxy) benzoic acid 清源创新实验室 2024-01-02 CN disclosed
US-20230422607-A1 AMINE COMPOUNDS AND ORGANIC LIGHT-EMITTING DEVICES USING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-12-28 US disclosed
CN-117255579-A Amine-containing compound, and light-emitting device, electronic device, and electronic device using same 三星显示有限公司 2023-12-19 CN disclosed
US-11832513-B2 Materials for electronic devices MERCK PATENT GMBH (DE) 2023-11-28 US disclosed
US-11832513-B2 Materials for electronic devices MERCK PATENT GMBH (DE) 2023-11-28 US disclosed
WO-2004050650-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER PHARMACEUTICALS CORPORATION (US) 2004-06-17 WO disclosed
WO-2004050651-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER PHARMACEUTICALS CORPORATION (US) 2004-06-17 WO disclosed
US-20040087791-A1 Bis(substituted propynyl)-substituted benzenes, pyridines, pyrimidines, pyrazines, pyridines, furans and pyrroles; e.g., 3,5-bis-(3-(4-aminomethylbenzylaminocarbonyloxy)prop-1-ynyl)--1 -hydroxymethylbenzene ALTANA PHARMA AG (DE) 2004-05-06 US disclosed
EP-1363874-A2 TRYPTASE INHIBITORS ALTANA Pharma AG (DE) 2003-11-26 EP disclosed
WO-2002066420-A2 TRYPTASE INHIBITORS ALTANA PHARMA AG (DE) 2002-08-29 WO disclosed
EP-0956312-B1 PROCESS FOR PRODUCING PHENYLENE-CONTAINING POLYMER AND FILM-FORMING MATERIAL JSR CORP (JP) 2001-10-10 EP disclosed
US-6300465-B1 Process for producing phenylene-containing polymer and film-forming material JSR CORPORATION (JP) 2001-10-09 US disclosed
US-3966728-A ANTIPEPTIC ULCER ACTIVITY NIPPON SHINYAKU CO., LTD. (JA) 1976-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11832513-B2 Materials for electronic devices PNMT, DDT, COMT PTPN2 2797/4885PTPN1 3476/4885PTPN6 2756/4885
US-20040087791-A1 Bis(substituted propynyl)-substituted benzenes, pyridines, pyrimidines, pyrazines, pyridines, furans and pyrroles; e.g., 3,5-bis-(3-(4-aminomethylbenzylaminocarbonyloxy)prop-1-ynyl)--1 -hydroxymethylbenzene TPSB2, TPSAB1, TPSG1 PTPN2 2526/4885PTPN1 2210/4885PTPN6 3263/4885
US-20230422607-A1 AMINE COMPOUNDS AND ORGANIC LIGHT-EMITTING DEVICES USING THE SAME L1CAM, SLC1A2, AOC2 PTPN2 4780/4885PTPN1 4772/4885PTPN6 4828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.